A 6 hour training event with Michael Gaudet, LICSW, LDCP
8:30 a.m. – 4:00 p.m. (registration begins at 8:00 a.m.)
PRESENTATION: This course will provide an updated version of the NIDA and SAMHSA’s Blending Initiative product, originally entitled “Buprenophine Treatment: A Training for Multidisciplinary Professionals”. The primary goal of this training package is to create awareness among addiction professionals about medications currently approved by the FDA and used in the treatment of opioid dependence. The course includes information about what to expect when someone is treated with medication, information about the legislation that permits office based buprenorphine treatment, the science of addiction, the mechanism of each medication, patient selection criteria and associated patient counseling and therapeutic issues. As a result of this training participants will:
- Learn about the history of opioid treatment in the United States;
- Discuss changes in the laws regarding treatment of opioid addiction and the implications for the treatment system;
- Learn how medication will benefit the delivery of opioid treatment and the types of medications used to treat opioid use disorder; and
- Possess knowledge about the demographics of people affected by opioid use disorder.
ABOUT THE PRESENTER: Michael Gaudet LICSW earned his undergraduate degree in 1981 at Bridgewater State College and his MSW from Rhode Island College in 1984. He is currently the Director of Quality Assurance for eleven outpatient mental health and substance abuse programs in Massachusetts, with a primary office at Arbour Counseling Services, Fall River, MA. In addition, he serves as the organization’s Compliance and Privacy Officer and is a surveyor for CARF International. Mike has extensive clinical and supervision experience in mental health and substance abuse treatment. He trains and consults across the country on clinical and professional growth topics, and, since 1986, is a faculty member of the New England Institute of Addiction Studies. He has been involved in several projects designed to advance the use of medication in substance abuse recovery, including the use of Methadone, Buprenorphine and Naltrexone, through the Addiction Technology Transfer Center of New England.
Fee: *NHADACA Members: $55; *Non-Members $65; *NBCC add $5. Lunch will be on your own. For registration information contact: 603-225-7060, email@example.com
6 Contact Hours Available
CRSW Performance Domains: 1, 3 & 4
LADC/MLADC Categories of Competence: 3, 6, 7, 12-16, 18
Certified Prevention Specialist Domains: 6
NBCC: LICSW/L-MFT/LCMHC (Category 1) & Psychologist Category A
NH Alcohol & Drug Abuse Counselors Association has been approved by NBCC as an Approved Continuing Education Provider. ACEP No 6754. Programs that do not qualify for NBCC credit are clearly identified. NHADACA is solely responsible for all aspects of the program.
PLEASE NOTE: Only one registrant per form. For multiple registrants you must register each one individually. Registration is not complete or guaranteed until payment is received. Payment by means other than credit card may slow down completion of registration. Checks and cash are still accepted, however, your registration will be placed on a pending list until payment is received. We strongly encourage payment by credit card for training of high demand topics. Thank you.